B

BCAX

Bicara Therapeutics

20.56

+0.46+2.29%
After Hours: 20.56  0.00  0.00%16:05 06/09 EDT
1D
5D
Daily
Weekly
Monthly
Quarterly
Yearly
OPEN/PREV CLOSE20.40/20.10
TODAY RANGE19.81-20.83
VOL619.08K
MARKET CAP1.35B
52 WEEK RANGE8.48-24.25
AVG VOL (3M)532.36K
% TURNOVER0.94%
TURNOVER--
P/E (TTM)-7.4178
% RANGE5.07%
EPS(TTM)-2.7717
P/E(FORWARD)-5.7915
P/B2.622
BVPS7.84
DIVIDEND--
P/S--
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP1.14B
SHARES OUTSTANDING65.70M
NEXT EARNINGS08/10-08/14
FREE FLOAT55.31M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
Same Industry
Name/Symbol
Change%
Price

R

Regeneron Pharmaceuticals

REGN

+1.07%
635.45

G

GridAI Tech

GRDX

+4.79%
6.35

B

BIONTECH

BNTX

-1.69%
88.08

聯合治療

UTHR

+0.40%
549.87

福泰製藥

VRTX

+1.15%
446.83

S

SIGA科技

SIGA

-2.93%
4.300

M

Moderna

MRNA

-8.04%
47.44

C

Charles Riv Labs Intl Inc

CRL

-2.40%
181.34

M

Medpace控股

MEDP

-0.97%
454.25

TLPH

--

I

ICON plc

ICLR

-2.19%
149.45

泰邦生物

CBPO

0.00%
119.99

I

Iqvia Hldgs Inc

IQV

-1.84%
183.45

MOLN

--

A

Arcturus醫療

ARCT

-9.20%
7.30

吉利德科學

GILD

-0.02%
129.16

PRAH

--

因塞特醫療

INCY

+1.13%
102.38

APVO

--

BSTC

--

Contact Us

Contact Number :+852 3852 8500
Monday 7:00 AM - Saturday 9:00 AM (HKT)
Service Email :service@webull.hk
Online Support: Monday - Friday: 9:00 - 16:00; 22:30 - 5:00 (HKT)
Business Cooperation :marketinghk@webull.hk
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language

English

©2026 Webull Securities Limited. All rights reserved.